Basic Information
| Terpenoid ID | TKC095493 |
|
| Cell line | 0 | |
| Protein target | 32 | |
| DiseaseNCIT | 0 | |
| ORDO | 0 | |
| ICD | 93 |
| Terpenoid ID | TKC095493 |
|
| Cell line | 0 | |
| Protein target | 32 | |
| DiseaseNCIT | 0 | |
| ORDO | 0 | |
| ICD | 93 |
| ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
|---|---|---|---|---|---|---|---|
| TKC095493 | HepG2 | 14125.0 | nM | Potency | C3728 | Orphanet_449 | |
| TKC095493 | HEK293 | 11220.0 | nM | Potency | |||
| TKC095493 | SN12C | SN-12C | 2023.0 | nM | GI50 | C9385 | Orphanet_217071 |
| TKC095493 | MDA-N | MDAN | 1675.0 | nM | GI50 | C3802 | |
| TKC095493 | NCI-H23 | NCI.H23; NCI H23; H-23; H23; NCIH23 | 2123.0 | nM | GI50 | C3512 | |
| TKC095493 | ACHN | 2618.0 | nM | GI50 | C6975 | Orphanet_319298 | |
| TKC095493 | UO-31 | UO.31; UO31; U031 | 2564.0 | nM | GI50 | C9385 | Orphanet_217071 |
| TKC095493 | HOP-92 | HOP 92; HOP.92; HOP92; Hop92; Hopkins-92 | 1919.0 | nM | GI50 | C2926 | |
| TKC095493 | HL-60 | HL 60; HL.60 HL60; Human Leukemia-60 | 415.0 | nM | GI50 | C9154 | Orphanet_519 |
| TKC095493 | SF-539 | SF-539; SF-539 BT; SF.539; SF 539 | 1786.0 | nM | GI50 | C3796 | Orphanet_251576 |
| TKC095493 | DU-145 | DU-145; Du-145; DU 145; DU_145; DU.145; Duke University 145 | 2065.0 | nM | GI50 | C4863 | |
| TKC095493 | SK-MEL-5 | SK-Mel-5; SK MEL 5; SK.MEL.5; SK-MEL5; SKMel-5; SKMEL-5; SKMEL5; SKMel5; SKmel5; AA-Mel | 1600.0 | nM | GI50 | C3510 | |
| TKC095493 | Malme-3M | MALME-3M; MALME 3M; Malme-3 M; MALME.3M; Malme3M; MALME3M; Malme-3 Monolayer | 2208.0 | nM | GI50 | C3224 | |
| TKC095493 | K562 | K562; K.562; K 562; KO; GM05372; GM05372E | 1186.0 | nM | GI50 | C9110 | Orphanet_521 |
| TKC095493 | OVCAR-3 | Ovcar-3; OVCAR 3; OVCAR.3; NIH:OVCAR-3; NIH:Ovcar-3; NIH:OVCAR3; NIH-OVCAR-3; NIHOVCAR3; OVCAR3; Ovcar3 | 2056.0 | nM | GI50 | C105555 | |
| TKC095493 | A498 | A498 | 2432.0 | nM | GI50 | C9385 | Orphanet_217071 |
| TKC095493 | MOLT-4 | Molt-4; MOLT 4; Molt 4; MOLT.4; MOLT4; Molt4; GM02219; GM02219C; GM2219C; GM02219D | 1337.0 | nM | GI50 | C9142 | Orphanet_99861 |
| TKC095493 | HOP-62 | HOP 62; Hop 62; HOP.62; HOP62; Hop62; Hopkins-62 | 2761.0 | nM | GI50 | C3512 | |
| TKC095493 | NCI/ADR-RES | NCI/ADR-RES; NCI.ADR.RES; NCIADR.RES; NCI/ADRRES; NCIADRRES; ADR-RES; MCF-7/ADR; MCF-7/ADR-RES; MCF-7/AdrR; MCF-7/Adr; MCF-7/adr; MCF-7ADR; MCF7-ADR; MCF7ADR; OVCAR-8/ADR; OVCAR8/ADR | 2897.0 | nM | GI50 | C105555 | |
| TKC095493 | U-251 | U-251 MG; U-251-MG; U-251_MG; U251-MG; U251MG; U-251; U251; U251n; U251N; 251 MG; 251MG; 251 MG(6) | 1968.0 | nM | GI50 | C60781 | Orphanet_94 |
| TKC095493 | OVCAR-8 | OVCAR 8; NIH:OVCAR-8; OVCAR8; Ovcar8; OVCAR.8; OVCA8 | 2698.0 | nM | GI50 | C105555 | |
| TKC095493 | OVCAR-5 | OVCAR 5; NIH:OVCAR-5; OVCAR.5; OVCAR5; Ovcar5; OVCA5 | 2382.0 | nM | GI50 | C105555 | |
| TKC095493 | SNB-19 | SNB.19; SNB19; Surgical Neurology Branch-19 | 3148.0 | nM | GI50 | C60781 | Orphanet_94 |
| TKC095493 | SR | SR-786; SR786 | 1361.0 | nM | GI50 | C37193 | Orphanet_300895 |
| TKC095493 | MDA-MB-231 | MDA_MB_231; MDA-MB 231; MDA.MB.231; MDA MB 231; MDA MB231; MDA Mb231; MDA-MB231; MDAMB-231; MDAMB231; MDA-231; MDA-231P; MDA231; MDA231-BRE; MB231; MD Anderson-Metastatic Breast-231 | 1914.0 | nM | GI50 | C5214 | |
| TKC095493 | TK-10 | TK.10; TK 10; TK10 | 3334.0 | nM | GI50 | C4033 | Orphanet_319276 |
| TKC095493 | SW-620 | SW-620; SW 620; SW.620 | 1758.0 | nM | GI50 | C4349 | |
| TKC095493 | NCI-H522 | NCI.H522; H522; H-522; NCI-522; NCI522; NCIH522 | 1837.0 | nM | GI50 | C3512 | |
| TKC095493 | M14 | M14-MEL; UCLA-SO-M14; UCLA SO M14; UCLA-SO-14; UCLASO-M14; Melanoma 14; M-14 | 1820.0 | nM | GI50 | C3802 | |
| TKC095493 | KM12 | KM-12; KM.12 | 1754.0 | nM | GI50 | C4910 | |
| TKC095493 | NCI-H322M | NCI.H322M; H322M; H-322M; H-322m | 3581.0 | nM | GI50 | C2923 | |
| TKC095493 | RPMI-8226 | RPMI 8226; RPMI.8226; RPMI8226; RPMI no. 8226; RPMI no 8226; RPMI #8226; 8226; RPMI 8226/S; RPMI-8226S; RPMI8226/S; 8226/S; Roswell Park Memorial Institute 8226; GM02132; GM2132; GM 2132; GM02132C; Simpson | 1208.0 | nM | GI50 | C3242 | Orphanet_29073 |
| TKC095493 | OVCAR-4 | OVCAR 4; NIH:OVCAR-4; NIH:OVCAR4; OVCAR.4; OVCAR4; Ovcar4 | 2123.0 | nM | GI50 | C105555 | |
| TKC095493 | LOX IMVI | LOX/IMVI; LOX IMVI; LOXIM-VI; LOXIMVI; LOX | 1782.0 | nM | GI50 | C3802 | |
| TKC095493 | BT-549 | BT 549; BT.549; BT549 | 2244.0 | nM | GI50 | C4194 | |
| TKC095493 | SK-MEL-2 | SK-Mel-2; SK-Mel 2; SK-mel-2; SK-MEL2; SK.MEL.2; SK Mel 2; SK MEL 2; SKMEL-2; SKMEL2; SKmel2; SK-ML2; SKml2 | 1820.0 | nM | GI50 | C3224 | |
| TKC095493 | A549 | 3048.0 | nM | GI50 | C3512 | ||
| TKC095493 | SNB-75 | SNB.75; SNB75; Surgical Neurology Branch-75 | 2576.0 | nM | GI50 | C3058 | Orphanet_360 |
| TKC095493 | HCC 2998 | HCC-2998; HCC.2998; HCC 2998; Hamon Cancer Center 2998 | 1726.0 | nM | GI50 | C4349 | |
| TKC095493 | HCT-15 | HCT-15; HCT.15; HCT15 | 1995.0 | nM | GI50 | C4349 | |
| TKC095493 | HCT-116 | HCT-116; HCT.116; HCT_116; HCT116; HCT116wt; CoCL2 | 1671.0 | nM | GI50 | C4910 | |
| TKC095493 | SF-268 | SF-268; SF.268; SF 268 | 2099.0 | nM | GI50 | C60781 | Orphanet_94 |
| TKC095493 | MCF7 | 1837.0 | nM | GI50 | C4194 | ||
| TKC095493 | EKVX | 2985.0 | nM | GI50 | C3512 | ||
| TKC095493 | PC-3 | PC3; PC.3 | 2259.0 | nM | GI50 | C4863 | |
| TKC095493 | T47D | 1845.0 | nM | GI50 | C4194 | ||
| TKC095493 | SK-OV-3 | SKOV-3; SK-OV3; SK.OV.3; SKOV3; Skov3; SKO3 | 4467.0 | nM | GI50 | C7978 | |
| TKC095493 | UACC-62 | UACC 62; UACC.62; UACC62; University of Arizona Cell Culture-62 | 1455.0 | nM | GI50 | C3224 | |
| TKC095493 | NCI-H460 | NCI.H460; H460; H-460; NCIH460; NCI-HUT-460; NCI-460 | 1923.0 | nM | GI50 | C4450 | |
| TKC095493 | MDA-MB-435 | MDA-MB435; MDAMB435; MDA.MB.435; MDA-435; MDA 435; MDA435; MD Anderson-Metastatic Breast-435 | 1626.0 | nM | GI50 | C3802 | |
| TKC095493 | CAKI-1 | CAL 1; Centre Antoine Lacassagne-1 | 3365.0 | nM | GI50 | C3224 | |
| TKC095493 | IGROV-1 | Igrov-1; IGROV 1; IGR-OV1; IGROV1; Igrov1; IGR.OV1; IGROV; OV1/P; OV1/p; OV1-P | 2812.0 | nM | GI50 | C7979 | Orphanet_454723 |
| TKC095493 | SF-295 | SF-295; SF.295; SF 295 | 1778.0 | nM | GI50 | C3058 | Orphanet_360 |
| TKC095493 | Hs-578T | HS 578T; Hs-578T; HS-578T; Hs_578t; Hs-578-T; HS-578-T; Hs 578.T; HS578T; Hs578T; Hs578t; HS0578T; 578T; HS578; Hs578; Homo sapiens No. 578, tumor cells | 2143.0 | nM | GI50 | C4194 | |
| TKC095493 | 786-0 | 786-o; 786O; 786-0; 786.O; 786-O RCC; RCC 786-O; RCC_7860; RCC 7860; 7860; 786-0WT | 2404.0 | nM | GI50 | C9385 | Orphanet_217071 |
| TKC095493 | CCRF-CEM | CCRF/CEM; CCRFCEM; CCRF.CEM; CCRF CEM; CCRF; CEM; CEM-CCRF; CEM-CCRF (CAMR); CCRF/CEM/0; CEM/0; CEM-0; CCRF-CEM/S; GM03671; GM03671C | 150.0 | nM | GI50 | C7953 | Orphanet_99861 |
| TKC095493 | UACC-257 | UACC 257; UACC.257; UACC257; University of Arizona Cell Culture-257 | 1845.0 | nM | GI50 | C3224 | |
| TKC095493 | NCI-H226 | NCI.H226; NCI H226; H226; H-226; HUT-226; HUT 226; NCIH226 | 2477.0 | nM | GI50 | C45662 | Orphanet_50251 |
| TKC095493 | HT-29 | HT 29; HT29 | 2393.0 | nM | GI50 | C4349 | |
| TKC095493 | SK-MEL-28 | SK-Mel-28; SK.MEL.28; SK-MEL 28; SK MEL-28; SK MEL 28; SK Mel 28; SKMel-28; SKMEL-28; SK-MEL28; SK-Mel28; SK Mel28; SKMEL28; SKMel28; SKmel28; SKML-28; SK28; AU-Mel; P-36; P36 | 1596.0 | nM | GI50 | C3510 | |
| TKC095493 | COLO 205 | Colo 205; CoLo 205; COLO-205; Colo-205; COLO.205; Colo205; COLO205; Co 205; Colorado 205 | 1928.0 | nM | GI50 | C4349 | |
| TKC095493 | RXF 393 | RXF393L; RXF-393 L; RXF-393; RXF 393; RXF.393; RXF393; RXF 393NL | 1472.0 | nM | GI50 | C9385 | Orphanet_217071 |
| ID | Uniport | Pref_name | Gene name | value | unit | type |
|---|---|---|---|---|---|---|
| TKC095493 | P04062 | Lysosomal acid glucosylceramidase | GBA1 | 10000 | nM | Potency |
| TKC095493 | P10636 | Microtubule-associated protein tau | MAPT | 7943 | nM | Potency |
| TKC095493 | Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | TDP1 | 9200 | nM | Potency |
| TKC095493 | P08684 | Cytochrome P450 3A4 | CYP3A4 | 1585 | nM | AC50 |
| TKC095493 | O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | IDH1 | 8200 | nM | Potency |
| TKC095493 | P43220 | Glucagon-like peptide 1 receptor | GLP1R | 6310 | nM | Potency |
| TKC095493 | P84022 | Mothers against decapentaplegic homolog 3 | SMAD3 | 12589 | nM | Potency |
| TKC095493 | Q06710 | Paired box protein Pax-8 | PAX8 | 8190 | nM | AC50 |
| TKC095493 | Q16236 | Nuclear factor erythroid 2-related factor 2 | NFE2L2 | 20596 | nM | Potency |
| TKC095493 | Q99700 | Ataxin-2 | ATXN2 | 31623 | nM | Potency |
| TKC095493 | O75496 | Geminin | GMNN | 9200 | nM | Potency |
| TKC095493 | P38398 | Breast cancer type 1 susceptibility protein | BRCA1 | 35481 | nM | Potency |
| TKC095493 | P05177 | Cytochrome P450 1A2 | CYP1A2 | 3981 | nM | AC50 |
| TKC095493 | P07550 | Beta-2 adrenergic receptor | ADRB2 | 28184 | nM | Potency |
| TKC095493 | P10635 | Cytochrome P450 2D6 | CYP2D6 | 3981 | nM | AC50 |
| TKC095493 | P11712 | Cytochrome P450 2C9 | CYP2C9 | 316 | nM | Potency |
| TKC095493 | P32245 | Melanocortin receptor 4 | MC4R | >64584 | nM | IC50 |
| TKC095493 | P33261 | Cytochrome P450 2C19 | CYP2C19 | 3162 | nM | AC50 |
| TKC095493 | Q96QE3 | ATPase family AAA domain-containing protein 5 | ATAD5 | 16354 | nM | Potency |
| TKC095493 | P63096 | Guanine nucleotide-binding protein G | GNAI1 | 50119 | nM | Potency |
| TKC095493 | Q6W5P4 | Neuropeptide S receptor | NPSR1 | 10000 | nM | Potency |
| TKC095493 | O15296 | Polyunsaturated fatty acid lipoxygenase ALOX15B | ALOX15B | 3162 | nM | Potency |
| TKC095493 | Q9F4F7 | 4'-phosphopantetheinyl transferase ffp | ffp | 70795 | nM | Potency |
| TKC095493 | P10520 | Streptokinase A | ska | 1801 | nM | EC50 |
| TKC095493 | Q16665 | Hypoxia-inducible factor 1-alpha | HIF1A | 3162 | nM | Potency |
| TKC095493 | Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | BAZ2B | 89125 | nM | Potency |
| TKC095493 | P16050 | Polyunsaturated fatty acid lipoxygenase ALOX15 | ALOX15 | 3162 | nM | Potency |
| TKC095493 | Q8IUX4 | DNA dC->dU-editing enzyme APOBEC-3F | APOBEC3F | 3548 | nM | Potency |
| TKC095493 | P51450 | Nuclear receptor ROR-gamma | Rorc | 12589 | nM | Potency |
| TKC095493 | P02545 | Prelamin-A/C | LMNA | 12589 | nM | Potency |
| TKC095493 | P04637 | Cellular tumor antigen p53 | TP53 | 3162 | nM | Potency |
| TKC095493 | Q194T2 | Non-structural protein 1 | NS1 | 12589 | nM | Potency |
| TKC095493 | P62826 | GTP-binding nuclear protein Ran | RAN | 14581 | nM | Potency |
| TKC095493 | P11166 | Solute carrier family 2, facilitated glucose transporter member 1 | SLC2A1 | 8 | % | Inhibition |
| TKC095493 | O61059 | Glucose transporter | LmGT2 | 7 | % | Inhibition |
| TKC095493 | O97467 | Hexose transporter 1 | ht1 | 7 | % | Inhibition |
| Uniport ID | Uniport Name | ICD-11 |
|---|---|---|
| P10636 | TAU_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
| P10636 | TAU_HUMAN | Alzheimer disease [ICD-11: 8A20] |
| P10636 | TAU_HUMAN | Mild neurocognitive disorder [ICD-11: 6D71] |
| P10636 | TAU_HUMAN | Choreiform disorder [ICD-11: 8A01] |
| P10636 | TAU_HUMAN | Parkinsonism [ICD-11: 8A00] |
| P10636 | TAU_HUMAN | Central nervous system disease [ICD-11: 8A04-8D87] |
| P10636 | TAU_HUMAN | Neurodegenerative disorder [ICD-11: 8A20-8A23] |
| P08684 | CP3A4_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| P08684 | CP3A4_HUMAN | Atopic eczema [ICD-11: EA80] |
| P08684 | CP3A4_HUMAN | Anxiety disorder [ICD-11: 6B00-6B0Z] |
| O75874 | IDHC_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
| O75874 | IDHC_HUMAN | Liver cancer [ICD-11: 2C12] |
| O75874 | IDHC_HUMAN | Malignant haematopoietic neoplasm [ICD-11: 2B33] |
| O75874 | IDHC_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| O75874 | IDHC_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
| O75874 | IDHC_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| P43220 | GLP1R_HUMAN | Cardiovascular disease [ICD-11: BA00-BE2Z] |
| P43220 | GLP1R_HUMAN | Obesity [ICD-11: 5B80-5B81] |
| P43220 | GLP1R_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
| P43220 | GLP1R_HUMAN | Type-1/2 diabete [ICD-11: 5A10-5A11] |
| P43220 | GLP1R_HUMAN | Acute diabete complication [ICD-11: 5A2Y] |
| P43220 | GLP1R_HUMAN | Diabetes mellitus [ICD-11: 5A10] |
| P43220 | GLP1R_HUMAN | Dyspepsia [ICD-11: MD92] |
| P43220 | GLP1R_HUMAN | Irritable bowel syndrome [ICD-11: DD91] |
| P43220 | GLP1R_HUMAN | Intracranial injury [ICD-11: NA07] |
| P43220 | GLP1R_HUMAN | Non-alcoholic fatty liver disease [ICD-11: DB92] |
| P84022 | SMAD3_HUMAN | Herpes simplex infection [ICD-11: 1F00] |
| P84022 | SMAD3_HUMAN | Kidney fibrosis [ICD-11: GC01] |
| Q16236 | NF2L2_HUMAN | Ataxic disorder [ICD-11: 8A03] |
| Q16236 | NF2L2_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
| Q16236 | NF2L2_HUMAN | Glaucoma [ICD-11: 9C61] |
| Q16236 | NF2L2_HUMAN | Lung cancer [ICD-11: 2C25] |
| Q16236 | NF2L2_HUMAN | Macular degeneration [ICD-11: 9B75] |
| Q16236 | NF2L2_HUMAN | Melanoma [ICD-11: 2C30] |
| Q16236 | NF2L2_HUMAN | Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z] |
| Q16236 | NF2L2_HUMAN | Pulmonary hypertension [ICD-11: BB01] |
| Q16236 | NF2L2_HUMAN | Subarachnoid haemorrhage [ICD-11: 8B01] |
| Q16236 | NF2L2_HUMAN | Urinary system clinical sympton [ICD-11: MF8Y] |
| Q16236 | NF2L2_HUMAN | Non-alcoholic fatty liver disease [ICD-11: DB92] |
| Q16236 | NF2L2_HUMAN | Alpha-1-antitrypsin deficiency [ICD-11: 5C5A] |
| Q16236 | NF2L2_HUMAN | Motor neuron disease [ICD-11: 8B60] |
| Q16236 | NF2L2_HUMAN | Multiple sclerosis [ICD-11: 8A40] |
| P07550 | ADRB2_HUMAN | Glaucoma [ICD-11: 9C61] |
| P07550 | ADRB2_HUMAN | Asthma [ICD-11: CA23] |
| P07550 | ADRB2_HUMAN | Chronic obstructive pulmonary disease [ICD-11: CA22] |
| P07550 | ADRB2_HUMAN | Conduction disorder [ICD-11: BC63] |
| P07550 | ADRB2_HUMAN | Melanoma [ICD-11: 2C30] |
| P07550 | ADRB2_HUMAN | Preterm labour/delivery [ICD-11: JB00] |
| P07550 | ADRB2_HUMAN | Sleep-related breathing disorder [ICD-11: 7A4Z] |
| P07550 | ADRB2_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
| P07550 | ADRB2_HUMAN | Stomach cancer [ICD-11: 2B72] |
| P07550 | ADRB2_HUMAN | Hypertension [ICD-11: BA00-BA04] |
| P07550 | ADRB2_HUMAN | Supraventricular tachyarrhythmia [ICD-11: BC81] |
| P07550 | ADRB2_HUMAN | Cachexia [ICD-11: MG20] |
| P07550 | ADRB2_HUMAN | Dermal/subcutaneous connective tissue atrophy/degeneration [ICD-11: EE40] |
| P07550 | ADRB2_HUMAN | Skin and skin-structure infection [ICD-11: 1F28-1G0Z] |
| P07550 | ADRB2_HUMAN | Bladder disorder [ICD-11: GC01] |
| P07550 | ADRB2_HUMAN | Obesity [ICD-11: 5B80-5B81] |
| P07550 | ADRB2_HUMAN | Ejaculatory dysfunction [ICD-11: HA03] |
| P07550 | ADRB2_HUMAN | Cardiovascular disease [ICD-11: BA00-BE2Z] |
| P10635 | CP2D6_HUMAN | Insomnia [ICD-11: 7A00-7A0Z] |
| P10635 | CP2D6_HUMAN | Malaria [ICD-11: 1F40-1F45] |
| P10635 | CP2D6_HUMAN | Migraine [ICD-11: 8A80] |
| P11712 | CP2C9_HUMAN | Bacterial infection [ICD-11: 1A00-1C4Z] |
| P32245 | MC4R_HUMAN | Acute diabete complication [ICD-11: 5A2Y] |
| P32245 | MC4R_HUMAN | Hypoactive sexual desire dysfunction [ICD-11: HA00] |
| P32245 | MC4R_HUMAN | Intellectual development disorder [ICD-11: LD90] |
| P32245 | MC4R_HUMAN | Large intestine motility disorder [ICD-11: DB32] |
| P32245 | MC4R_HUMAN | Obesity [ICD-11: 5B80-5B81] |
| P32245 | MC4R_HUMAN | Pituitary hypofunction [ICD-11: 5A61] |
| P32245 | MC4R_HUMAN | Sexual dysfunction [ICD-11: HA00-HA01] |
| P32245 | MC4R_HUMAN | Alzheimer disease [ICD-11: 8A20] |
| P32245 | MC4R_HUMAN | Asthma [ICD-11: CA23] |
| P32245 | MC4R_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
| P32245 | MC4R_HUMAN | General pain disorder [ICD-11: 8E43] |
| P32245 | MC4R_HUMAN | Atopic eczema [ICD-11: EA80] |
| P32245 | MC4R_HUMAN | Metabolic disorder [ICD-11: 5C50-5D2Z] |
| P32245 | MC4R_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
| P32245 | MC4R_HUMAN | Anorexia nervosa [ICD-11: 6B80] |
| P32245 | MC4R_HUMAN | Cachexia [ICD-11: MG20] |
| Q16665 | HIF1A_HUMAN | Adrenomedullary hyperfunction [ICD-11: 5A75] |
| Q16665 | HIF1A_HUMAN | Brain cancer [ICD-11: 2A00] |
| Q16665 | HIF1A_HUMAN | Lymphoma [ICD-11: 2A80-2A86] |
| Q16665 | HIF1A_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| Q16665 | HIF1A_HUMAN | Pulmonary hypertension [ICD-11: BB01] |
| P04637 | P53_HUMAN | Arterial occlusive disease [ICD-11: BD40] |
| P04637 | P53_HUMAN | Lip/oral cavity/pharynx neoplasm [ICD-11: 2B6E] |
| P04637 | P53_HUMAN | Metastatic liver/bile duct neoplasm [ICD-11: 2D80] |
| P04637 | P53_HUMAN | Transplant rejection [ICD-11: NE84] |
| P04637 | P53_HUMAN | Ovarian dysfunction [ICD-11: 5A80] |
| P04637 | P53_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
| P04637 | P53_HUMAN | Bladder cancer [ICD-11: 2C94] |
| P04637 | P53_HUMAN | Brain cancer [ICD-11: 2A00] |
| P04637 | P53_HUMAN | Colorectal cancer [ICD-11: 2B91] |
| P04637 | P53_HUMAN | Esophageal cancer [ICD-11: 2B70] |
| P04637 | P53_HUMAN | Head and neck cancer [ICD-11: 2D42] |
| P04637 | P53_HUMAN | Mature B-cell leukaemia [ICD-11: 2A82] |
| P04637 | P53_HUMAN | Myelodysplastic syndrome [ICD-11: 2A37] |
| P04637 | P53_HUMAN | Ovarian cancer [ICD-11: 2C73] |
| P04637 | P53_HUMAN | Pancreatic cancer [ICD-11: 2C10] |
| P04637 | P53_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| P04637 | P53_HUMAN | Stomach cancer [ICD-11: 2B72] |
| P04637 | P53_HUMAN | Cervical cancer [ICD-11: 2C77] |
| P04637 | P53_HUMAN | Endometrial cancer [ICD-11: 2C76] |
| P04637 | P53_HUMAN | Fallopian tube cancer [ICD-11: 2C74] |
| P04637 | P53_HUMAN | Liposarcoma [ICD-11: 2B59] |
| P04637 | P53_HUMAN | Malignant haematopoietic neoplasm [ICD-11: 2B33] |
| P04637 | P53_HUMAN | Peritoneal cancer [ICD-11: 2C51] |
| P04637 | P53_HUMAN | Toxicity [ICD-11: N.A.] |
| P04637 | P53_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| P04637 | P53_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
| P04637 | P53_HUMAN | Kidney failure [ICD-11: GB60-GB6Z] |
| P04637 | P53_HUMAN | Hearing disorder [ICD-11: AB50-AB57] |
| P11166 | GTR1_HUMAN | Skin disease [ICD-11: EA00-EM0Z] |
| O97467 | O97467_PLAFA | Malaria [ICD-11: 1F40-1F45] |